FDA Inspection
Hospira, Inc.Hospira, Inc. – FDA Inspection, Nov 21, 2019
Record Details
This FDA Inspection record concerns Hospira, Inc., with an inspection on November 21, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Hospira, Inc.
- Inspection Date
- November 21, 2019
- Product Type
- Drugs
View Company Profile
ID · 8bc1ca51-7f35-4184-ac20-80876c3d27fd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1110899
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hospira, Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2025 | Not classified | Atlanta District Office | |
| November 14, 2023 | OAI | Atlanta District Office | |
| February 2, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 26, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 24, 2015 | VAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for Hospira, Inc.
- FDA Inspection 1251941 - 2025-02-07
- FDA Inspection 1223090 - 2023-11-14
- FDA Inspection 1039547 - 2018-02-02
- FDA Inspection 984874 - 2016-05-26
- FDA Inspection 942202 - 2015-09-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.